YEARS Core® was designed from the ground up as a clinical translation of epidemiology. Drawing on evidence from some of the world’s largest population studies, we reverse-engineered which diagnostics and biomarkers most reliably predict age-related disease. The result is a targeted panel of 25+ functional examinations and 80+ biomarkers that capture the earliest, silent deviations in organ, metabolic, and vascular health. This framework delivers a scientifically rigorous baseline—enabling precise, personalized strategies to slow age-related decline and extend healthspan.
 

The Evolve® Lab Panel builds on Core with 120+ biomarkers from blood and urine. It includes advanced hormones (DHEA-S, Testosterone, Estradiol, SHBG), vitamins and trace elements (B12, A, K2, Selenium, Zinc), and functional markers such as oxidized LDL, IGF-1, Lp-PLA2, Interleukin-6, Homocysteine, Leptin, and Omega-3/6. These parameters characterize metabolic, cardiovascular, hormonal, and inflammatory status, allowing early identification of risk patterns and guiding precise, personalized prevention.

This liquid biopsy test rules out cancer using a simple blood sample, identifying apoptosis-resistant circulating tumor-associated cells (C-ETACs) with high specificity (96%-99%) and sensitivity (65%-89%), with sensitivity increasing as tumors progress. Designed for individuals aged 40-70 (or 35+ with a family history of cancer), it enables proactive screening before symptoms appear. Our liquid biopsy supports remission monitoring, benign condition evaluation, and routine cancer surveillance. Using advanced cell-enrichment technology, it ensures precise detection of malignancies. 

The Whole-Body MRI is an advanced modality for preventive health monitoring, using a proprietary YEARS sequence across neurological, vascular, and oncological domains. It identifies subclinical structural changes relevant to disorders such as multiple sclerosis, brain tumors, aneurysms, fatty liver, intra-abdominal fat, and vascular abnormalities—key markers of metabolic dysfunction. This multi-organ scan also evaluates lung, liver, and spinal health, providing a comprehensive overview of potential oncological and systemic risks.

As part of the Evolve® Program, blood, stool, urine, and saliva are processed into 70 cryopreserved samples, including immune cells (PBMCs), plasma, serum, red blood cells, and genetic material such as ccfDNA, mRNA, and microbiome DNA. These samples capture a biological snapshot at collection, creating a resource for future testing. Cryopreserving viable cells, especially PBMCs, provides a form of immune “backup” that may support future applications in immunotherapy, regenerative medicine, and biotechnology—depending on scientific progress. Banking biomaterials today secures optionality for tomorrow’s medical innovations.

The YEARS Performance Battery provides a precise diagnostic profile of fitness, mobility, and strength. Using 3D body scanning, VALD movement and force diagnostics, and ergospirometry, it identifies asymmetries, weaknesses, and metabolic limits. These findings directly translate into targeted exercise, nutrition, and recovery strategies—helping optimize performance, prevent injury, and extend physical resilience. For example, detecting declining strength or impaired balance enables early interventions to prevent frailty and reduce future fall risk.

Your care is continuously guided through tailored monitoring and regular check-ins — both remote and in-person. Based on your goals, we select the most relevant tools, such as CGM, sleep tracking, or blood pressure monitoring. Optional coaching in fitness, nutrition, and sleep ensures your strategy remains focused, adaptive, and always one step ahead.